Take Control of Your Cancer Treatment Journey with Genome Signature (HRD) Testing
Facing a cancer diagnosis can feel overwhelming, but having the right information empowers you to make confident treatment decisions. Our Genome Signature (HRD) test provides the critical genomic insights your oncologist needs to personalise your cancer treatment plan, giving you the best possible chance for successful outcomes.
Understanding Your Genome Signature (HRD) Test
The Genome Signature (HRD) test is a sophisticated genomic analysis that identifies Homologous Recombination Deficiency in your cancer cells. This revolutionary approach helps determine whether your cancer will respond better to certain targeted therapies, particularly PARP inhibitors. Using cutting-edge Next Generation Sequencing technology, we analyse both your tumour tissue and blood samples to provide comprehensive genomic profiling that guides personalised treatment decisions.
Think of it as a roadmap for your cancer treatment – it helps your medical team choose the most effective route rather than taking uncertain detours.
Who Should Consider Genome Signature (HRD) Testing?
This test is particularly valuable for patients diagnosed with:
- Ovarian cancer patients considering targeted therapy options
- Breast cancer patients, especially those with triple-negative or BRCA-related cancers
- Pancreatic cancer patients exploring personalised treatment approaches
- Prostate cancer patients seeking advanced treatment guidance
- Patients whose cancers have shown resistance to standard treatments
- Individuals with family history of cancer seeking comprehensive genomic analysis
If you’re feeling uncertain about which treatment path to take, this test provides the clarity and confidence you need.
Why Genome Signature (HRD) Testing Matters for Your Health
This advanced testing offers significant benefits for your cancer journey:
- Personalised Treatment Planning: Helps your oncologist select therapies most likely to work for your specific cancer type
- Reduced Treatment Side Effects: Avoid ineffective treatments and their unnecessary side effects
- Improved Treatment Outcomes: Increases the likelihood of successful treatment response
- Peace of Mind: Provides scientific confidence in your treatment decisions
- Cost-Effective Care: Prevents spending on treatments that may not work for your cancer
Early genomic insights can make a profound difference in your treatment success and quality of life.
Understanding Your Test Results
Your results will be clearly explained by our medical team and provided to your oncologist. We ensure you understand:
- Whether your cancer shows Homologous Recombination Deficiency
- What this means for your treatment options
- How the results guide targeted therapy decisions
- Next steps in your treatment planning
Our team provides comprehensive support to help you and your family understand the implications of your results, reducing anxiety and building confidence in your treatment path.
Transparent Pricing – Investing in Your Health
| Service | Regular Price | Special Price |
|---|---|---|
| Genome Signature (HRD) Test | ZAR 90,000 |
Test Details:
- Turnaround Time: 3-4 weeks
- Sample Requirements: Tumour tissue + Peripheral Blood
- Components: Paraffin embedded tissue blocks + EDTA Vacutainer (2ml) + Streck tube
- Method: Next Generation Sequencing (NGS)
Considering the potential to avoid ineffective treatments and their costs, this test represents significant long-term value for your health investment.
Why Trust Oracle Genomics?
We understand that genomic testing requires absolute confidence and reliability. That’s why we provide:
- Nationwide Coverage: Available across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Medical Expertise: Tests conducted under specialist supervision
- Accuracy Guarantee: Advanced NGS technology for precise results
- Patient-Centred Care: Empathetic support throughout your testing journey
- Doctor Collaboration: Results shared directly with your treating physician
Important Note: This test requires a doctor’s prescription, except for surgery and pregnancy cases or people planning to travel abroad.
Take the Next Step in Your Cancer Journey
Don’t leave your treatment decisions to chance. The insights from Genome Signature (HRD) testing could be the key to more effective, personalised cancer care.
Limited Time Offer: Secure your special price of ZAR 90,000 (regularly ZAR 120,000) and take control of your cancer treatment planning. Results delivered in 3-4 weeks with nationwide availability.
Every day matters in cancer treatment. Early genomic insights can significantly impact your treatment success and quality of life. Contact us today to begin your personalised testing journey.
